Novelty in no-reflow management in STEMI patients

Facilitators: F. Alfonso, B. Faurie

Summary

Discover novel approaches to manage no-reflow phenomenon in STEMI patients. This session covers innovative therapies including the OPTI-STEMI trial strategies, mechanical thrombectomy, pharmacological interventions with Cangrelor, and super saturated oxygen therapy targeting coronary microcirculation preservation.

Presentations available when logged in:

  • Novel strategies to reduce microvascular obstruction in primary PCI: the OPTI-STEMI trial
  • EnVast mechanical thrombectomy for patients with myocardial infarction and large thrombus burden
  • No-reflow and coronary slow flow after STEMI and the role of Cangrelor
  • Super saturated oxygen therapy in patients with STEMI and action on coronary microcirculation